JZ-IV-10
200px | |
Systematic (IUPAC) name | |
---|---|
(+)-2-([(3R,4S)-1-methyl-4-(4-chlorophenyl)piperidin-3-yl]methylthio)-N-isopropylacetamide | |
Identifiers | |
PubChem | CID 11291199 |
Chemical data | |
Formula | C18H27ClN2OS |
Molar mass | 354.937 g/mol[[Script error: No such module "String".]] |
Script error: No such module "collapsible list". |
JZ-IV-10 ("compound 16e") is a piperidine derivative related to nocaine which is a highly potent triple reuptake inhibitor (SNDRI).[1] The eugeroic modafinil, was used as a lead to fuel these compounds' discovery (J. Zhou, et al. 2004).[2] Although it turns out that the QSAR of the pharmacophoric elements do not appear to be strongly similar. The other isomers were also prepared, although they are weaker than the R,S probes invented in the current study (R. He, et al. 2005).[3]
JZ # | R | X | Y | [3H]NE | [3H]DA | [3H]5HT |
III-82 → ? | Me | -CO2H | 70.2 → ? | 121.2 → ? | 269.9 → ? | |
III-48 → III-59 | Ester | OMe | 25 → 53 | 80 → 231 | 208 → 809 | |
IV-22 → ? | H | 10 → 31.1 | 114 → 107.8 | 170 → 774.9 | ||
IV-25 → IV-37 | Me | Amide | NH2 | 39 → 178 | 159 → 209 | 557 → 5790 |
H | 10 → 31.1 | 114 → 107.8 | 170 → 774.9 | |||
III-62 → III-85 | Me | HNOH | 15 → 12 | 85 → 55 | 227 → 1795 | |
IV-5 → IV-14 | HNMe | 25 → 86 | 13 → 164 | 110 → 2033 | ||
IV-23 → IV-27 | -NMe2 | 27 → 1249 | 116 → 2884 | 88 → 924 | ||
IV-10 → IV-15 | NHPri | 0.8 → 20 | 1.0 → 248 | 1.1 → 473 | ||
IV-7 → IV-16 | -N(CH2)5 | 0.68 → 460 | 83 → 379 | 4.5 → 825 | ||
III-84 → IV-34 | H2 | OH | 0.94 → 42 | 16 → 12 | 158 → 2183 | |
IV-35 → IV-36 | OMe | 6 → 25 | 50 → 15 | 191 → 469 | ||
III-86 → III-91 | OAc | 3.6 → 29 | 35 → 9 | 57 → 87 | ||
III-87 → III-90 | OBz | 4.5 → 18 | 68 → 32 | 6.7 → 199 | ||
IV-17 → IV-21 | Het | 31.5 → 217.6 | 125.7 → 1,653 | 220.9 → 1,079 |
Upon "treatment" of the ligands with (H2O2 + AcOH) the sulfur atom is oxidized. The resultant molecules then lose most of their potency. This is not a major concern though (c.f. cimetidine, ranitidine). Little has been reported about the SAR of modafinil itself, and it is interesting to consider how these new findings could be applied retrospectively. The NRI selective molecules were employed as brain imaging agents to unravel details about the NE transporter.[4] NRIs are important probes, but they do not function as robust reinforcers.[5]
References
Cite error: Invalid <references>
tag;
parameter "group" is allowed only.
<references />
, or <references group="..." />
- ↑ WO 2005041875
- ↑ Zhou, J.; He, R.; Johnson, K.; Ye, Y.; Kozikowski, A. (2004). "Piperidine-based nocaine/modafinil hybrid ligands as highly potent monoamine transporter inhibitors: efficient drug discovery by rational lead hybridization". Journal of medicinal chemistry. 47 (24): 5821–5824. doi:10.1021/jm040117o. PMC 1395211 Freely accessible. PMID 15537337. More than one of
|author2=
and|last2=
specified (help); More than one of|author3=
and|last3=
specified (help); More than one of|author4=
and|last4=
specified (help); More than one of|author5=
and|last5=
specified (help) - ↑ He, R.; Kurome, T.; Giberson, K.; Johnson, K.; Kozikowski, A. (2005). "Further structure-activity relationship studies of piperidine-based monoamine transporter inhibitors: effects of piperidine ring stereochemistry on potency. Identification of norepinephrine transporter selective ligands and broad-spectrum transporter inhibitors". Journal of Medicinal Chemistry. 48 (25): 7970–7979. doi:10.1021/jm050694s. PMID 16335921. More than one of
|author2=
and|last2=
specified (help); More than one of|author3=
and|last3=
specified (help); More than one of|author4=
and|last4=
specified (help); More than one of|author5=
and|last5=
specified (help) - ↑ Musachio, J.; Hong, J.; Ichise, M.; Seneca, N.; Brown, A.; Liow, J.; Halldin, C.; Innis, R.; Pike, V. (2006). "Development of new brain imaging agents based upon nocaine-modafinil hybrid monoamine transporter inhibitors". Bioorganic & medicinal chemistry letters. 16 (12): 3101–3104. doi:10.1016/j.bmcl.2006.03.066. PMID 16621532.
- ↑ Wee, S.; Wang, Z.; He, R.; Zhou, J.; Kozikowski, A.; Woolverton, W. (2006). "Role of the increased noradrenergic neurotransmission in drug self-administration". Drug and alcohol dependence. 82 (2): 151–157. doi:10.1016/j.drugalcdep.2005.09.002. PMID 16213110. More than one of
|author2=
and|last2=
specified (help); More than one of|author3=
and|last3=
specified (help); More than one of|author4=
and|last4=
specified (help); More than one of|author5=
and|last5=
specified (help); More than one of|author6=
and|last6=
specified (help)
- Pages with script errors
- Pages using duplicate arguments in template calls
- Pages with broken file links
- Infobox drug tracked parameters
- Chemical articles without CAS Registry Number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugboxes with an unspecified ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Stimulants
- Amides
- Piperidines
- Organochlorides
- 2Fix
- Pages with citations having redundant parameters